These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18080768)

  • 1. Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status.
    Ates Y; Degertekin B; Erdil A; Yaman H; Dagalp K
    Dig Dis Sci; 2008 Aug; 53(8):2215-21. PubMed ID: 18080768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
    Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum adipokines in inflammatory bowel disease.
    Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
    World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease.
    Eivindson M; Nielsen JN; Grønbaek H; Flyvbjerg A; Hey H
    Horm Res; 2005; 64(1):9-15. PubMed ID: 16088202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the relationship between serum ghrelin, C-reactive protein and interleukin-6 levels, and disease activity in inflammatory bowel diseases.
    Cekic C; Arabul M; Alper E; Pakoz ZB; Saritas E; Yuksel ; Ünsal B
    Hepatogastroenterology; 2014; 61(133):1196-200. PubMed ID: 25436282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
    Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerative Colitis and Crohn's Disease Are Associated with Decreased Serum Selenium Concentrations and Increased Cardiovascular Risk.
    Castro Aguilar-Tablada T; Navarro-Alarcón M; Quesada Granados J; Samaniego Sánchez C; Rufián-Henares JÁ; Nogueras-Lopez F
    Nutrients; 2016 Dec; 8(12):. PubMed ID: 27916926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obestatin/ghrelin ratio: a new activity index in inflammatory bowel diseases.
    Alexandridis E; Zisimopoulos A; Liratzopoulos N; Katsos I; Manolas K; Kouklakis G
    Inflamm Bowel Dis; 2009 Oct; 15(10):1557-61. PubMed ID: 19408254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania.
    Dumitrescu G; Mihai C; Dranga M; Prelipcean CC
    World J Gastroenterol; 2014 Mar; 20(9):2392-6. PubMed ID: 24605037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.
    Kapsoritakis AN; Kapsoritaki AI; Davidi IP; Lotis VD; Manolakis AC; Mylonis PI; Theodoridou AT; Germenis AE; Potamianos SP
    BMC Gastroenterol; 2008 Nov; 8():55. PubMed ID: 19036126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease.
    Street ME; de'Angelis G; Camacho-Hübner C; Giovannelli G; Ziveri MA; Bacchini PL; Bernasconi S; Sansebastiano G; Savage MO
    Horm Res; 2004; 61(4):159-64. PubMed ID: 14691340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red cell distribution width for assessment of activity of inflammatory bowel disease.
    Cakal B; Akoz AG; Ustundag Y; Yalinkilic M; Ulker A; Ankarali H
    Dig Dis Sci; 2009 Apr; 54(4):842-7. PubMed ID: 18716874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
    Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
    Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment.
    Neubauer K; Kempinski R; Matusiewicz M; Bednarz-Misa I; Krzystek-Korpacka M
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30986917
    [No Abstract]   [Full Text] [Related]  

  • 17. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
    Eivindson M; Grønbaek H; Flyvbjerg A; Frystyk J; Zimmermann-Nielsen E; Dahlerup JF
    Growth Horm IGF Res; 2007 Feb; 17(1):33-40. PubMed ID: 17126585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
    Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
    Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic features of inflammatory bowel disease in a remission phase of the disease activity.
    Capristo E; Mingrone G; Addolorato G; Greco AV; Gasbarrini G
    J Intern Med; 1998 May; 243(5):339-47. PubMed ID: 9651555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved.
    Guijarro LG; Cano-Martínez D; Toledo-Lobo MV; Salinas PS; Chaparro M; Gómez-Lahoz AM; Zoullas S; Rodríguez-Torres R; Román ID; Monasor LS; Ruiz-Llorente L; Del Carmen Boyano-Adánez M; Guerra I; Iborra M; Cabriada JL; Bujanda L; Taxonera C; García-Sánchez V; Marín-Jiménez I; Acosta MB; Vera I; Martín-Arranz MD; Mesonero F; Sempere L; Gomollón F; Hinojosa J; Alvarez-Mon M; Gisbert JP; Ortega MA; Hernández-Breijo B; On Behalf Of The Predicrohn Study Group From Geteccu
    Biomed Pharmacother; 2021 Dec; 144():112239. PubMed ID: 34601192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.